Australia’s medical cannabis industry started with high hopes — finally giving patients safe, legal access to the medicine they need. But years later, many are still frustrated. Prices are sky-high, quality is hit-or-miss, and big companies often seem more focused on profits than patients. Instead of listening to real feedback about weak flower or bad service, the industry too often shrugs it off. And with corporate giants running the show, cannabis is treated more like a cash crop than a crucial medicine for people who actually rely on it.